Stockreport

Ocugen to Present at April 2026 Investor and Industry Conferences

Ocugen, Inc.  (OCGN) 
PDF MALVERN, Pa., April 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness [Read more]